Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Nilssen · SciRah

Researcher profile · Semantic Scholar

Y. Nilssen

Share profile

Y. Nilssen — researcher profile on SciRah

h-index: 15
Works: 44
Citations: 659

Most-cited papers

Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study
S. Mcphail, Ruth Swann, S. Johnson, M. Barclay +44 more
2022The Lancet Oncology102 citations Open access
Semantic Scholar
Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage
Y. Nilssen, T. Strand, L. Fjellbirkeland, K. Bartnes +4 more
2016International Journal of Cancer58 citations Open access
Semantic Scholar
Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway
Katrine Damgaard Skyrud, F. Bray, M. Eriksen, Y. Nilssen +1 more
2016International Journal of Cancer49 citations Open access
Semantic Scholar
Utilizing national patient-register data to control for comorbidity in prognostic studies
Y. Nilssen, T. Strand, R. Wiik, I. Bakken +3 more
2014Clinical Epidemiology41 citations Open access
Semantic Scholar
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
T. Robsahm, P. Helsing, Y. Nilssen, L. Vos +3 more
2018Clinical Epidemiology40 citations Open access
Semantic Scholar
Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016.
O. Brustugun, B. Grønberg, L. Fjellbirkeland, N. Helbekkmo +7 more
2018Lung Cancer34 citations Open access
Semantic Scholar
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study
H. H. Hektoen, K. Tsuruda, L. Fjellbirkeland, Y. Nilssen +2 more
2024British Journal of Cancer31 citations Open access
Semantic Scholar
Lung cancer survival in Norway, 1997–2011: from nihilism to optimism
Y. Nilssen, T. Strand, L. Fjellbirkeland, K. Bartnes +1 more
2015European Respiratory Journal31 citations Open access
Semantic Scholar
Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience.
S. Fosså, Y. Nilssen, R. Kvåle, E. Hernes +2 more
2014Urology31 citations Open access
Semantic Scholar
Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway.
Y. Nilssen, O. Brustugun, Morten Tandberg Eriksen, Johanne Gulbrandsen +3 more
2019Cancer Epidemiology28 citations Open access
Semantic Scholar
Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
Y. Nilssen, M. Eriksen, M. Guren, B. Møller
2021BMC Cancer22 citations Open access
Semantic Scholar
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016
Y. Nilssen, O. Brustugun, M. Eriksen, E. Haug +2 more
2020BMC Cancer19 citations Open access
Semantic Scholar
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
S. McPhail, M. Barclay, R. Swann, Shane A. Johnson +52 more
2024The Lancet Oncology18 citations Open access
Semantic Scholar
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
S. McPhail, M. Barclay, Shane A. Johnson, R. Swann +55 more
2024The Lancet Oncology18 citations Open access
Semantic Scholar
Increase in curative treatment and survival of lung cancer in Norway 2001–2016
S. Solberg, Y. Nilssen, O. Brustugun, T. Grimsrud +11 more
2019European Journal of Epidemiology15 citations Open access
Semantic Scholar
Clustering and trajectories of key noncommunicable disease risk factors in Norway: the NCDNOR project
K. Dalene, Simon Lergenmuller, E. Sund, L. Hopstock +5 more
2023Scientific Reports14 citations Open access
Semantic Scholar
Concordance between clinical and pathology TNM-staging in lung cancer.
S. Solberg, Y. Nilssen, Odd Terje Brustugun, Per Magnus Haram +5 more
2022Lung Cancer14 citations Open access
Semantic Scholar
Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
Y. Nilssen, S. Solberg, O. Brustugun, B. Møller +3 more
2023European Journal of Cardio-Thoracic Surgery13 citations Open access
Semantic Scholar
Distribution and characteristics of malignant tumours by lung lobe
Y. Nilssen, O. Brustugun, L. Fjellbirkeland, Å. Helland +3 more
2024BMC Pulmonary Medicine12 citations Open access
Semantic Scholar
Real-World Data on EGFR and ALK Testing and TKI Usage in Norway—A Nation-Wide Population Study
I. J. Eide, Y. Nilssen, E. Stensland, O. Brustugun
2023Cancers11 citations Open access
Semantic Scholar
Factors associated with emergency-related diagnosis, time to treatment and type of treatment in 5713 lung cancer patients
Y. Nilssen, O. Brustugun, B. Møller
2021European Journal of Public Health11 citations Open access
Semantic Scholar
Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study
O. Brustugun, Y. Nilssen, I. J. Eide
2021Acta oncologica9 citations Open access
Semantic Scholar
Educational disparities in cancer incidence, stage, and survival in Oslo
Afaf Al-Rammahy, E. Fadum, Y. Nilssen, I. K. Larsen +2 more
2024Research in Health Services & Regions8 citations Open access
Semantic Scholar
Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018
Gustav Graabak, B. Grønberg, M. Sandvei, Y. Nilssen +1 more
2021JTO Clinical and Research Reports8 citations Open access
Semantic Scholar
Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends.
Y. Nilssen, O. Brustugun, L. Fjellbirkeland, B. Grønberg +6 more
2024Clinical Lung Cancer6 citations Open access
Semantic Scholar
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016
Y. Nilssen, O. Brustugun, M. Eriksen, M. Guren +4 more
2022BMC Cancer5 citations Open access
Semantic Scholar
Improving communication of cancer survival statistics—feasibility of implementing model-based algorithms in routine publications
T. Myklebust, B. Aagnes, Y. Nilssen, Mark Rutherford +5 more
2023British Journal of Cancer4 citations Open access
Semantic Scholar
Factors affecting outcome in resected EGFR-mutated lung cancer
I. J. Eide, Y. Nilssen, M. Lund-Iversen, O. Brustugun
2022Acta oncologica3 citations Open access
Semantic Scholar
A comprehensive nationwide registry study of noncommunicable disease comorbidities and death in cancer patients in Norway—the NCDNOR project
Simon Lergenmuller, T. Robsahm, Y. Nilssen, K. Dalene +7 more
2026Scientific Reports1 citations Open access
Semantic Scholar
Maximal Local Privacy Loss—A New Method for Privacy Evaluation of Synthetic Datasets
Sigrid Leithe, Bjørn Møller, B. Aagnes, Y. Nilssen +2 more
2026Statistics in Medicine1 citations
Semantic Scholar
Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).
E. Stensland, S. Stensgaard, I. Eide, Y. Nilssen +7 more
2026Lung Cancer1 citations Open access
Semantic Scholar
Long-term trends in the clinical management and outcomes of patients with gastroesophageal cancer in Norway
A. Kolstad, G. Emanuel, G. Hjortland, Y. Nilssen +3 more
2025Acta oncologica1 citations Open access
Semantic Scholar
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study
M. Barclay, S. McPhail, Shane A. Johnson, R. Swann +36 more
2025BMJ Oncology1 citations Open access
Semantic Scholar
366P Correlation of geographic and temporal variations in diagnostic imaging and diagnosis of early-stage lung cancer
E. Krager, Y. Nilssen, O. Brustugun
2026ESMO Open0 citations Open access
Semantic Scholar
Survival of all cancer sites combined: Partitioning of temporal changes into cancer, non-cancer and case-mix.
Paul C. Lambert, Y. Nilssen, T. Myklebust, B. Aagnes +2 more
2026Cancer Epidemiology0 citations Open access
Semantic Scholar
Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway
S. Solberg, K. S. Slørdahl, Marianne Aanerud, O. Brustugun +4 more
2025BJC Reports0 citations Open access
Semantic Scholar
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study.
M. Barclay, S. McPhail, Shane A. Johnson, R. Swann +29 more
2025Cancer Epidemiology0 citations Open access
Semantic Scholar
Educational differences in cancer incidence, stage at time of diagnosis, and survival in Norway
Kenz Al-Shather, Y. Nilssen, I. K. Larsen, Erlend Hem +1 more
2025Research in Health Services & Regions0 citations Open access
Semantic Scholar
Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS‐PNET in Oslo 2005–2017
P. Niehusmann, E. Stensvold, H. Leske, T. Pietsch +6 more
2022Pediatric Blood & Cancer0 citations Open access
Semantic Scholar
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016
Y. Nilssen, O. Brustugun, M. Eriksen, M. Guren +4 more
2022BMC Cancer0 citations Open access
Semantic Scholar
“Lung cancer survival in Norway, 1997–2011: from nihilism to optimism.” Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjørn Møller. Eur Respir J 2016; 47: 275–287.
Y. Nilssen, T. Strand, L. Fjellbirkeland, K. Bartnes +1 more
2016European Respiratory Journal0 citations Open access
Semantic Scholar
A population-based study of lung cancer in Norway – the importance of resection rate and factors associated with treatment and survival
Y. Nilssen
20160 citations
Semantic Scholar
Utilizing national patient-register data to control for comorbidity in prognostic studies
Y. Nilssen, T. Strand, R. Wiik, I. J. Bakken +3 more
20140 citations
Semantic Scholar
Survival Analysis using Integrated Nested Laplace Approximations: A Case Study of House Sparrows from Aldra
Y. Nilssen
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Brustugun×18
Invite
O. Brustugun — researcher profile on SciRah
B. Møller×12
Invite
B. Møller — researcher profile on SciRah
L. Fjellbirkeland×9
Invite
L. Fjellbirkeland — researcher profile on SciRah
T. Strand×7
Invite
T. Strand — researcher profile on SciRah

×7

Invite

Å. Helland — researcher profile on SciRah

Invite

S. Solberg — researcher profile on SciRah

Invite

B. Møller — researcher profile on SciRah

Andriana Barisic×5

Invite

Andriana Barisic — researcher profile on SciRah

Invite

Norah Finn — researcher profile on SciRah

Invite

D. Huws — researcher profile on SciRah

Invite

G. Musto — researcher profile on SciRah

N. Saint-Jacques×5

Invite

N. Saint-Jacques — researcher profile on SciRah